Ginkgo Bioworks Holdings, Inc. DNA
NYSE
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -290.80M | -304.39M | -312.76M | -339.55M | -315.19M |
| Total Depreciation and Amortization | 25.95M | 28.78M | 30.80M | 32.79M | 36.49M |
| Total Amortization of Deferred Charges | 27.00M | 27.10M | 27.10M | 27.10M | 26.40M |
| Total Other Non-Cash Items | 104.75M | 130.41M | 124.60M | 128.87M | 141.44M |
| Change in Net Operating Assets | -37.13M | -48.12M | -40.79M | -15.03M | -126.85M |
| Cash from Operations | -170.24M | -166.22M | -171.06M | -165.82M | -237.71M |
| Capital Expenditure | -4.56M | -1.98M | -7.67M | -21.37M | -36.46M |
| Sale of Property, Plant, and Equipment | 574.00K | 574.00K | 574.00K | 57.00K | 648.00K |
| Cash Acquisitions | -- | -- | -- | 0.00 | 0.00 |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 60.49M | -17.07M | -233.20M | -327.16M | -250.05M |
| Cash from Investing | 56.50M | -18.47M | -240.29M | -348.47M | -285.86M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -68.00K | -166.00K | -354.00K | -532.00K | -708.00K |
| Issuance of Common Stock | 36.52M | 19.47M | 19.47M | 10.32M | 0.00 |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -1.90M | -1.34M | -1.34M | -355.00K | -265.00K |
| Cash from Financing | 34.55M | 17.96M | 17.78M | 9.43M | -973.00K |
| Foreign Exchange rate Adjustments | -145.00K | -2.00K | 201.00K | 280.00K | 152.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -79.34M | -166.74M | -393.37M | -504.58M | -524.39M |